全文获取类型
收费全文 | 409篇 |
免费 | 22篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 6篇 |
妇产科学 | 3篇 |
基础医学 | 45篇 |
口腔科学 | 3篇 |
临床医学 | 13篇 |
内科学 | 135篇 |
神经病学 | 6篇 |
特种医学 | 5篇 |
外科学 | 8篇 |
综合类 | 9篇 |
预防医学 | 149篇 |
眼科学 | 1篇 |
药学 | 43篇 |
中国医学 | 1篇 |
肿瘤学 | 8篇 |
出版年
2024年 | 1篇 |
2023年 | 34篇 |
2022年 | 22篇 |
2021年 | 31篇 |
2020年 | 61篇 |
2019年 | 21篇 |
2018年 | 39篇 |
2017年 | 21篇 |
2016年 | 22篇 |
2015年 | 25篇 |
2014年 | 30篇 |
2013年 | 35篇 |
2012年 | 3篇 |
2011年 | 5篇 |
2010年 | 13篇 |
2009年 | 10篇 |
2008年 | 5篇 |
2007年 | 7篇 |
2006年 | 11篇 |
2005年 | 4篇 |
2004年 | 5篇 |
2003年 | 7篇 |
2002年 | 4篇 |
2001年 | 5篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1994年 | 2篇 |
1991年 | 1篇 |
1986年 | 1篇 |
1982年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有436条查询结果,搜索用时 25 毫秒
91.
《Vaccine》2017,35(32):3922-3929
BackgroundHuman papillomavirus vaccines have demonstrated remarkable efficacy against persistent infection and disease associated with vaccine-incorporated genotypes and a degree of efficacy against some genetically related, non-vaccine-incorporated genotypes. The vaccines differ in the extent of cross-protection against these non-vaccine genotypes. Data supporting the role for neutralizing antibodies as a correlate or surrogate of cross-protection are lacking, as is a robust assessment of the seroconversion rates against these non-vaccine genotypes.MethodsWe performed a systematic review and meta-analysis of available data on vaccine-induced neutralizing antibody seropositivity to non-vaccine incorporated HPV genotypes.ResultsOf 304 articles screened, 9 were included in the analysis representing ca. 700 individuals. The pooled estimate for seropositivity against HPV31 for the bivalent vaccine (86%; 95%CI 78–91%) was higher than that for the quadrivalent vaccine (61%; 39–79%; p = 0.011). The pooled estimate for seropositivity against HPV45 for the bivalent vaccine (50%; 37–64%) was also higher than that for the quadrivalent vaccine (16%; 6–36%; p = 0.007). Seropositivity against HPV33, HPV52 and HPV58 were similar between the vaccines. Mean seropositivity rates across non-vaccine genotypes were positively associated with the corresponding vaccine efficacy data reported from vaccine trials.ConclusionsThese data improve our understanding of vaccine-induced functional antibody specificity against non-vaccine incorporated genotypes and may help to parameterize vaccine-impact models and improve patient management in a post-vaccine setting. 相似文献
92.
93.
《Disability and health journal》2020,13(1):100838
BackgroundStroke can cause severe brain lesions, leading to multiple cognitive, emotional and motor disorders. In fact, it is one of the main causes of death and disability worldwide, with a negative impact on quality of life for both patient and caregiver. Home automation (also known as domotics) could allow stroke patients to manage and improve their daily lives.ObjectiveThe aim of our pilot study was to evaluate the effects of domotics on cognitive functions and personal/social autonomy in patients with stroke.MethodsWe enrolled 40 patients affected by chronic stroke undergoing neurorehabilitation at IRCCS Centro Neurolesi (Messina, Italy), between June 2017 and March 2019. All of the patients were randomized into either the control group (undergoing traditional training based on face-to-face interaction between therapist and patient, and practical activities), or the experimental group (undergoing Home Automation training). Each participant was evaluated before and immediately after the training period. Each different training consisted of 3 sessions per week for eight weeks (i.e. a total of 24 sessions), each session lasting about 60 min. For both the conventional and experimental trainings, treatments were performed in groups, and all the patients were provided with the same amount of treatment.ResultsPatients in the experimental group showed a greater improvement in cognitive and social performance, as compared to the control group.ConclusionOur study shows that domotics could be effective in improving social and cognitive functioning, autonomy and functional recovery in patients affected by chronic stroke. 相似文献
94.
BackgroundThe government of Tanzania launched an opioid treatment program (OTP), using methadone, in Dar es Salaam in February of 2011. Hepatitis C virus (HCV) is a leading cause of morbidity and mortality globally, especially among people who inject drugs (PWID). We conducted a cross-sectional study among PWID engaged in OTP in Dar es Salaam to describe the prevalence and predictors of HCV antibody serostatus.MethodsRoutine programmatic data on patients enrolled in Muhimbili National Hospital’s OTP clinic from February 2011 to January 2013 were utilized. Multivariable Poisson regression was used to examine factors associated with HCV antibody serostatus.ResultsA total of 630 PWID enrolled into the OTP clinic during the study period, seven percent of which were women. The overall seroprevalence of HCV antibody was 57% (95% Confidence interval: 53–61%). In adjusted analysis, methadone patients who used heroin for 5–10 years (adjusted prevalence ratio; aPR = 1.41; 95% CI: 1.10–1.81) and >10 years (aPR = 1.48; 95% CI: 1.17–1.88) were more likely to be HCV antibody positive, compared to patients who used heroin for <5 years. Patients who reported sharing needles or other equipment at their last injection (aPR = 1.20; 95% CI: 1.01–1.41; p = 0.022), being arrested (aPR = 1.20; 95% CI: 1.04–1.40; p = 0.012) and who were HIV-positive (aPR = 1.84; 95% CI: 1.56–2.16; p < 0.001) were also more likely to be HCV antibody positive than their counterparts.ConclusionOur observed HCV antibody prevalence among PWID engaged in OTP is higher than previously reported estimates in Dar es Salaam. Predictors of HCV antibody serostatus in this sample were similar to those found among PWID in many other settings. Integrating HCV care and treatment into OTP clinics should be considered, leveraging lessons learned from the integration of HIV services into OTP. Global efforts to develop HCV care and treatment programs in low and middle-income countries are critical, especially among PWID who have a high burden of HCV. 相似文献
95.
96.
《Vaccine》2020,38(16):3255-3260
IntroductionDespite an effective vaccine, hepatitis B virus (HBV) infection continues to impose a large burden of disease globally. Until childhood immunisation achieves high adult population coverage, people who inject drugs (PWID), including prison inmates remain at risk. PWID have a higher prevalence of HBV than the wider population, and lower rates of vaccine-conferred immunity. This study sought to identify the incidence and predictors of HBV transmission and uptake of immunisation in PWID prisoners in Australia.MethodsLongitudinally collected, stored sera from subjects previously enrolled in a prospective study of hepatitis C in recently incarcerated PWID prisoners (n = 590) were serologically tested for HBV. Interviews recording demographic and behavioural risks were analysed. Multivariate statistical analyses were applied to identify associations of incident infection or immunisation.ResultsUpon imprisonment there were n = 373 (63%) individuals who were HBV susceptible, of whom 140 remained susceptible at the subsequent enrolment into the cohort, and had one or more follow-up visits (a total of 406.73 person years [p.y.]), and so were included in this analysis. There were 7 incident cases of HBV infection (1.7 per 100 p.y.) in this group, with transmission being associated with injecting drug use daily or more often. There were 48 individuals who were successfully immunised (11.8 per 100 p.y.) with younger age and continuous imprisonment predicting this outcome.ConclusionsThe Australian prison environment poses a high risk for HBV infection, and also provides an opportunity for immunisation for PWID. Further efforts are required to improve coverage and prevent ongoing transmissions. 相似文献
97.
Schematic diagram of the complications, possible treatments, and potential resistant target genes of IVIG resistant KD patient. 相似文献
98.
99.
100.